Arotech Co. (NASDAQ:ARTX) Given $4.50 Average Price Target by Analysts

Shares of Arotech Co. (NASDAQ:ARTX) have earned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.

Brokerages have set a one year consensus target price of $4.50 for the company and are anticipating that the company will post $0.06 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Arotech an industry rank of 37 out of 256 based on the ratings given to its competitors.

Several research firms recently commented on ARTX. Zacks Investment Research upgraded Arotech from a “hold” rating to a “buy” rating and set a $2.25 price target for the company in a research report on Thursday, August 8th. ValuEngine upgraded Arotech from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, TheStreet lowered Arotech from a “c” rating to a “d+” rating in a research report on Wednesday, May 22nd.

A number of large investors have recently bought and sold shares of ARTX. O Shaughnessy Asset Management LLC acquired a new stake in Arotech in the 1st quarter valued at about $78,000. Delek Group Ltd. boosted its position in Arotech by 12.6% in the 2nd quarter. Delek Group Ltd. now owns 58,985 shares of the aerospace company’s stock valued at $115,000 after buying an additional 6,587 shares during the period. ETF Managers Group LLC lifted its position in shares of Arotech by 26.3% during the 2nd quarter. ETF Managers Group LLC now owns 101,436 shares of the aerospace company’s stock worth $198,000 after purchasing an additional 21,149 shares during the last quarter. BlackRock Inc. lifted its position in shares of Arotech by 45.0% during the 2nd quarter. BlackRock Inc. now owns 112,810 shares of the aerospace company’s stock worth $224,000 after purchasing an additional 35,020 shares during the last quarter. Finally, Acadian Asset Management LLC raised its stake in Arotech by 141.0% during the 1st quarter. Acadian Asset Management LLC now owns 87,295 shares of the aerospace company’s stock worth $256,000 after acquiring an additional 51,067 shares in the last quarter. 33.90% of the stock is currently owned by institutional investors.

Shares of ARTX stock traded down $0.02 on Monday, reaching $2.39. The stock had a trading volume of 6,995 shares, compared to its average volume of 67,114. The stock has a market cap of $64.01 million, a P/E ratio of 14.94 and a beta of 1.26. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.43 and a current ratio of 1.70. The company has a 50 day simple moving average of $2.24 and a 200 day simple moving average of $2.46. Arotech has a 1 year low of $1.61 and a 1 year high of $3.66.

Arotech (NASDAQ:ARTX) last posted its quarterly earnings results on Wednesday, August 7th. The aerospace company reported $0.02 EPS for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.01. The business had revenue of $23.27 million for the quarter, compared to analysts’ expectations of $21.58 million. Arotech had a return on equity of 2.79% and a net margin of 0.19%. During the same period last year, the firm earned $0.03 earnings per share. On average, equities research analysts anticipate that Arotech will post 0.12 earnings per share for the current fiscal year.

About Arotech

Arotech Corporation provides defense and security products worldwide. The company's Training and Simulation division develops, manufactures, and markets multimedia and interactive digital solutions for engineering, use-of-force training, and operator training of military, law enforcement, security, emergency services, and other personnel.

See Also: What is the price-sales ratio?

Get a free copy of the Zacks research report on Arotech (ARTX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Arotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arotech and related companies with MarketBeat.com's FREE daily email newsletter.